European Journal of Physical Education and Sport Science
ISSN: 2501 - 1235
ISSN-L: 2501 - 1235
Available on-line at: www.oapub.org/edu
Volume 3 │ Issue 2 │ 2017
doi: 10.5281/zenodo.375659
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA)
THERAPY COMBINED WITH INTERVAL TRAINING EXERCISE
PROGRAM INCREASE THE CLAUDICATION DISTANCE
IN DIABETIC AND NON-DIABETIC PATIENTS WITH
FEMORO-POPLITEAL STENOSIS AGE OVER 55
Sid Solaković1, Mensur Vrcić2,
Ratko Pavlović3i, Rubina Alagaić-Alimanović4
¹Clinic for Vascular Surgery, Clinical Center of University of Sarajevo,
Bosnia and Herzegovina
²Faculty of Sport and Physical Education, University of Sarajevo,
Bosnia and Herzegovina
³Faculty of Physical Education and Sport, University of East Sarajevo, East Sarajevo,
Bosnia and Herzegovina
Clinic of Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo,
4
Bosnia and Herzegovina
Abstract:
The aim of the study was to estimate the increasing capability of claudications distance
in Fontaine's stage IIa of peripheral artery disease by influence of irregular
acetylsalicylic acid (ASA) therapy and life style modification, combined with regular
physical activity in diabetic and non-diabetic patients age over 55, in order to establish
if there were any improvements in claudication distance in the both groups of patients.
Method: This study was conducted from beginning of January, 2014 till end of January,
2015 at the Clinic of Vascular Surgery, Clinical Center University of Sarajevo and
included 60 patients age over 55 (30 patients who have diabetes mellitus and impellers
group consisting of 30 patients who were clinically confirmed not to have diabetes
mellitus), male and female, in stadium IIa of peripheral artery disease, with
manifestation of mild claudication symptoms. For the testing of statistical significance
of differences between the exanimated groups non-parameter and parameter tests were
used. The difference at a level of p<0,05 was statistically significant. Results: In all the
Copyright © The Author(s). All Rights Reserved.
© 2015 – 2017 Open Access Publishing Group
19
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
tested patients, we investigated increasing of claudications distance in diabetic and nondiabetic patients age over 55 years after one year study. Analysis shows the statistically
significant influence of antiplatelet therapy (Acetylsalicylic acid) (ASA), combined with
physical activity and life style modification on claudications distance over 500 meters in
25 patients without diabetes mellitus in (83% p<0,05), compared to 12 patents with
diabetes mellitus (40% p<0,05). Sixteen of non-diabetic patients (53%) were on
antiplatelet therapy over 4 years, on permanent treatment, compared to 4 diabetic
patients or (3%) (p<0,05). Conclusion: These clinical combined factors appeared to us as
being the main strategy of the therapeutic effect on enhancement of claudication
distance (Fontaine's stage II) of peripheral artery disease in patients with diabetes
mellitus, as well as patients without it.
Keywords: peripheral artery disease, claudication distance, diabetes mellitus, physical
activity, life style modification
1. Introduction
Peripheral artery disease (PAD) is a progressive disease occurring as a result of plaque
accumulation progress (claudication based on atherosclerosis pathologic process,
mostly on low extremities) in the arterial system that carries insufficient oxygenated
blood to the extremities as well as vital organs and it is not to be underestimate.
Peripheral artery disease (PAD) may cause barrier or blockage of vessels in the legs and
other parts of the body distant from the heart; pain occurs as the result of a reduction in
the blood flow to the muscles of the legs (Abbott, Brand, & Kannel, 1990; Creager,
Luscher, & Cosentino, 2003; Thomas, Lüscher, Mark, & Creager, 2003). The diagnosis of
PAD is difficult because most patients remain asymptomatic for many years. The
symptoms do not appear until there is at least 50% or more reduction and obstruction of
healthy lumen of Superficial Femoral Artery and Popliteal Artery narrowing stenosis
witch causing the claudication (Izquierdo-Porrera, Gardner, Bradham, et al. 2005; Steg,
Bhatt, Wilson, D’Agostino, et al.
). In Fontaine’s stage IIa of peripheral artery
disease the claudication symptomatology occurs in form of moderate and mild pain
symptoms, caused by a distance greater than 200 meters. Certain conditions or habits
may rise risk of peripheral artery disease (Thomas, Palumbo, Melton, et al. 2003; Belch,
MacCuish, Campbell, et al. 2008). These conditions are known as risk factors. Before age
55, women have a lower cardiovascular risk than men. Estrogen provides women with
certain protection against cardiovascular disease before menopause. After age 55,
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
20
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
however, the risk of cardiovascular disease increases in both, women and men.
Peripheral artery disease has been viewed as a disease of the lower extremities typified
by claudication symptoms (Criqui, Denenberg, et al. 1998; AACPR, 2004; Golomb,
Dang, & Criqui, 2006; Berger, Roncaglioni, Avanzini, et al. 2006). Patient with diabetes
mellitus has a two- to four times shorter life expectancy, referring to complications
caused by progression of cardiovascular disease. Diabetes and pre-diabetic stage highly
increase the risk of cardiovascular disease progression, more in female than in male.
(Arfvidsson, Wennmalm, Gelin, et al. 1992; Colwell, 1997; Ogawa, Nakayama,
Morimoto, et al. 2008). The mechanism of elevation incidence in cardiovascular disease
remains not entirely understood. In fact, having diabetes mellitus doubles a woman's
risk of developing cardiovascular disease (Larsen, & Lasen, 1966; Hayden, Pignone, &
Phillips, 2002). Patients with a history of peripheral artery disease have the same
relative risk of cardiovascular death as patients with coronary or cerebrovascular
disease (Thomas, Elliott, Naughton, 2009; Larose, Sigal, Khandwala, et al. 2012).
Peripheral artery disease is a result of atherosclerotic disease progression, and it
is not surprising that patients with peripheral artery disease are higher exposed to
myocardial infarction, stroke, and all-cause mortality risk (Snowling, Hopkins, 2006;
Gordon, Benson, Bird, et al. 2009; Colberg, Sigal, Fernhall, et al. 2010). The evidence
proved that lifestyle modification with dietary modification and smoking cessation,
combined with regular physical activity has an independent cardio-protective effect
which may reduce overall cardiovascular risk. Using acetylsalicylic acid therapy (75162 mg/d per day) in men age 45-79 years and women age 55-79 years, with or without
diabetes, is a primary prevention strategy in patients having increased cardiovascular
risk, including those who have additional risk factors (positive family history of
cardiovascular disease, hypertension, smoking, dyslipidemia, or albuminuria) (Cai,
Qiu, Ju, & Sun, 2014). The main mechanism of acetylsalicylic acid (ASA) is to block
thromboxane synthesis by acetylating platelet cyclooxygenase. This therapy has been
used as a primary and secondary strategy to prevent cardiovascular problems in nondiabetic and diabetic patients. Multiple studies and large-scale collaborative trials in
diabetic and non-diabetic patients, both male and female, confirmed that low-dose
Acetylsalicylic acid (ASA) therapy should be prescribed as a secondary prevention
strategy (Sigal, Kenny, Boulé, et al. 2007; Brun, Bordenave, Mercier, et al. 2008; Karstoft,
Winding, Knudsen, et al. 2013). The recognition that physical activity with life style
modification and low-dose of acetylsalicylic acid (ASA) 150 mg/ per day can increase
the symptoms reduction in stadium IIa of peripheral artery disease and reduce
progression of cardiovascular problems, caused the therapy became the most ideal
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
21
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
treatment in diabetic and non-diabetic patients, age over 55, with mild or moderate
claudication symptoms (AACPR, 2004; Ogawa, Nakayama, Morimoto, et al. 2008). This
strategy is a trend toward increasing risk reductions in diabetic and non-diabetic
patients, allowing significant increases in walking distance and improving quality of
life in general. Physical activity magnified blood flow through this collateral circuitry in
animal models of peripheral artery disease. Improvements in collateral-dependent
blood flow to hind limb muscles that occur with regular physical activity come to
remolding and enlargement of collateral vessels and alternative blood routes. The
capability of
physical activity combined with irregular acetylsalicylic acid (ASA)
therapy and life style modification to alter the reactivity of collateral vessels has
remained relatively unexplored (Jennings, Alberga, Sigal, et al. 2009; Plotnikoff, Eves,
Jung, et al. 2010).
The aim of the study was to estimate the increasing capability of mild
claudication distance in Fontaine's stage IIa of peripheral artery disease by influence of
irregular acetylsalicylic acid (ASA) therapy and life style modification with regular
physical activity in diabetic patients, without diabetic neuropathy and non-diabetic
patients, after one year study at the Clinic of vascular surgery Clinical Center
University of Sarajevo.
Picture 1: Digital subtraction angiography (DSA) medical report shows multiple
femoro-popliteal lesions significant hemodynamic obstructions of femoral and popliteal artery
lumen over 50% (Clinic for Vascular Surgery Clinical Center of University of Sarajevo, BIH)
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
22
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
2. Method
The research was executed as a case retrospective study, which included the period of
validity of one year; during it, the group of patients in stadium IIa of peripheral artery
disease with or without diabetes mellitus was observed. This study was conducted at
the Clinic of vascular surgery, Clinical Center University of Sarajevo and included 60
patients of both genders, age over 55, with verified Femoro-Popliteal Stenosis over 50%,
with or without diabetes mellitus, being in Fontaine’s stage IIa of peripheral artery
disease, with manifestations of mild claudication symptoms, who met the criteria for
being included in the study. Interval training program was composed as described:
walking of 30-60 minutes, with repetitions of 100-200m, middle intensity, fast walking
with a recovery period following each repetition, also with self-control heart frequency
120-155 beats/min at max. intensity of 60 to 70% of heart rate, during at least one year,
4-6 times a week. This study was conducted at the Clinic for vascular surgery, Centre of
Sarajevo University and included 60 patients, male and female, with diabetes mellitus
and without diabetes mellitus, which met the criteria for including in the study. Patients
were divided into two groups; the first group consisted of 30 diabetic patients with noninsulin resist. The first group consisted of 30 patients, who have diabetes mellitus;
impellers group consists of 30 patients, clinically confirmed not to have diabetes
mellitus. During period of one year research in non-diabetic and diabetic patients,
progress of underlying disease was not confirmed; diabetic neuropathy and the
presence of absence of lower limb and foot sensibility also, were not clinically
confirmed during the study period. During one year training program procedure all
diabetic patients were required to contact vascular surgeon and his medical team if
health conditions become progressively worse (ulcus throphoneuroticum/traumaticum,
other signs of foot ulceration, cold foot ischemia in progress, absence of sensibility,
cancer, heart-attack, angina pectoralis, insulin therapy modification, etc.). Diabetic
patients should also consume more complex carbohydrates, oligo and polysaccharides
in form of cereals, combined with glass of orange juice and certain quantity of still
water, at least one hour before working out. Main influence and attention of study is
dedicated to diabetic patients because of complications of underlying disease.
All the patients, in spite of basic recommendation concerning combined
treatment benefits (invasive or minimal-invasive reconstruction of PTA/stent/bypass)
denied and refuse surgical treatment and have chosen conservative method of curing.
The antiplatelet therapy in patients (diabetic and non-diabetic) was also changed (150
mg of acetylsalicylic acid (ASA) per day/75 mg each 12 hours during one year,
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
23
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
compared with 100 mg of acetylsalicylic acid (ASA) a day, before research started. At
the research beginning, all the patients were also physically examined by a medical
team, led by vascular surgeon and his medical team, as well as at the end of the
research. The study was approved by an institutional review board and all patients
gave their written consent.
3. Results
Table 1: Gender distribution in diabetic and non-diabetic patients
Group
Male
Gender
Female
Total
Patients who suffer from
Patients who didn’t suffer from
diabetes mellitus
diabetes mellitus
Total
N
23
25
48
%
76,7
83,3
80,0
N
7
5
12
%
23,3
16,7
20,0
N
30
30
60
%
50,0
50,0
100,0
Patients who suffer
Patients who didn’t suffer
Total
from diabetes mellitus
from diabetes mellitus
Table 2: The period of Acetylsalicylic acid (ASA) therapy in diabetic and
non-diabetic patients age over 55 years
Group
Dose of Acetylsalicylic acid (ASA)
150 mg/ per day
1 year of using Acetylsalicylic
N
2
13
15
acid (ASA) therapy
%
6,7
43,3
25,0
6 mounths of using
N
3
5
8
%
10,0
16,7
13,3
2 years of using Acetylsalicylic
N
4
3
7
acid (ASA) therapy
%
13,3
10,0
11,7
3 years of using Acetylsalicylic
N
5
5
10
acid (ASA) therapy
%
16,7
16,7
16,7
4 years of using Acetylsalicylic
N
16
4
20
acid (ASA) therapy
%
53,3
13,3
33,3
N
30
30
60
%
50,0
50,0
100,0
Acetylsalicylic acid (ASA)
therapy
Total
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
24
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
Table 3: Estimation of claudication distance in diabetic and
non-diabetic patients age over 55 years
Claudications distance with mild claudication symptoms in meters
Claudications distance in
meters
400m
500m
600m
700m
800m
900m
1000m
Total
Group
Patients who suffer from
Patients who didn’t suffer from
diabetes mellitus
diabetes mellitus
Total
N
3
2
5
%
10,0
6,7
8,3
N
4
3
7
%
13,3
10,0
11,7
N
9
4
13
%
30,0
13,3
21,7
N
7
10
17
%
23,3
33,3
28,3
N
5
5
10
%
16,7
16,7
16,7
N
2
5
7
%
6,7
16,7
11,7
N
0
1
1
%
,0
3,3
1,7
N
30
30
60
%
50,0
50,0
100,0
Table 4: Presence of a claudication distance with non-clinical symptoms of
Peripheral artery disease after one year research
Group
Yes
No
Total
Patients who didn’t suffer from
Patients who suffer from
diabetes mellitus
diabetes mellitus
Total
N
25
12
38
%
83,3
40,0
46,7
N
5
18
23
%
16,7
60,0
53,3
N
30
30
60
%
50,0
50,0
100,0
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
25
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
Table 5: Increasing of claudication distance in diabetic and non-diabetic patients
over 500m after one year research
Group
Yes
No
Total
Patients who did not suffer from
Patients who suffer from
diabetes mellitus
diabetes mellitus
Total
N
30
30
60
%
100
100
100
N
0
0
0
%
0
0
0
N
30
30
60
%
50,0
50,0
100,0
In our analysis we documented statistically significant difference in higher incidence
between patients using acetylsalicylic acid, compared with period before using ASA; in
16 (53%) patients with diabetes mellitus in over 4 years period (p<0.05). The 13 nondiabetic patient (43,3%) were statistically treated with acetylsalicylic acid in one year
period (p<0.05). Separate analysis was done in males and females, patients with or
without diabetes mellitus. Comparison of main values by gender shows that there were
more males represented in the group of diabetics (76,7%) and non-diabetics, (83,3%)
within no statistically significant differences within those groups (p>0.05). In this
research we also documented the evaluation of claudication distance in diabetic
patients and non-diabetic patients, which leads to conclusion that 10 (33,3%) of diabetic
patients have reported claudication distance over 700m, compared to 9 (30%) nondiabetic patient, which have reported claudication distance over 600m, with no
statistically significant differences in the groups (p>0.05). Only 3 (3,3%) non-diabetic
patients documented the claudication distance over 1000m (p>0.05). The lower
claudications distance of 400m was reported in 2 diabetic patients (6,7%) and 3 nondiabetic patients (10%).
4. Discussion
The study was based on data from history of disease and questionnaire carried out in
all patients. During this study we have concluded that patients age over 55, who
suffered from diabetes mellitus as a main unpredictable risk factor (Fontaine's stage IIa)
of peripheral artery disease also suffer from collateral circulation deficiency, as a result
of significant arterial destruction. Diabetes mellitus as accompanied disease of
peripheral artery disease may increase disorders, which affects, either directly or
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
26
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
indirectly the functions of the arterial and collateral arterial system. The differences in
effect of acetylsalicylic acid therapy between diabetic patient’s age over 55 without
diabetic neuropathy and non-diabetic patient’s age over 55 were detected. As a
summary review we have verified with continuous monitoring
the
statistical
significant presence of a claudication distance with non-clinical or subjective symptoms
of peripheral artery disease after one year of study in our data analysis in (83,3%) or 25
non-diabetic patients (p<0,05). We have proved the importance of connection between
diabetes and a progression of peripheral artery disease, so that those patients should be
more adequately treated by remolding the actual therapy. Enlargement of the collateral
vessels (alternative blood routes) in diabetic patients is a main problem of underlying
disease. Available evidence shows, however, that appropriate antiplatelet therapy in
form of acetylsalicylic acid, physical activity and life style modification tends to increase
the claudication distance and with mild symptomatic pain in Fontaine's stage IIa of
peripheral artery disease statistically only in case of non-diabetic patients. Strategies for
the body is to adapt and modified alternative blood circulation system by development
of smaller peripheral arteries that will provide many pathways of blood flow around
the ischemic area. This indicates that patients with mild claudicaton symptoms in
Fontaine's stage IIa, in order to follow this strategic concept should be able to increase
the claudication distance and return symptomatic stage of peripheral artery disease in
asymptomatic stage of peripheral artery disease.
Patients with diabetes have potentially high level of arterial system destruction,
increasing directly the cardiovascular risk and accelerating rapidly the development of
peripheral artery disease. Adequate, regular, and timely therapy may prevent or delay
these diabetic complications. Patient should be aware of the important relationship
between diabetes and atherosclerosis and be prepared to be appropriately medically
treated to reduce disability and avoid arterial diabetic complications. In study by
Edward P Weiss and co. „Effects of matched weight loss from calorie restriction, exercise, or
both on cardiovascular disease risk factors“: Reductions in body weight have substantial
beneficial effects on cardiovascular (CVD) risk factors, so that with certainty we have
proved that Interval Training Exercise Program and Life Style Modification (with sugar
intake restriction, and reducing animal fat nutrition source) is vascular-protective
modifying the alternative blood circulation with increasing the pain tolerance and
returning to asymptomatic stage of peripheral artery disease (Weiss, Albert, Reeds et al.
). Also the study by Byrne, Caulfield., & De Vito,
“Effects of Self-directed
Exercise Programmes on Individuals with Type 2 Diabetes Mellitus“ indicated that selfdirected exercise was found to be beneficial for diabetic individuals for improving
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
27
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
glycosylated hemoglobin, physical characteristics, cardiorespiratory fitness, functional
measures and other metabolic outcomes. Physical activity with life style modification
and appropriate antiplatelet therapy in form of acetylsalicylic acid 150mg/d (75 mg
every 12 hours) should be implemented in diabetic and non-diabetic patients and
unless it is contraindicated by risk of gastrointestinal bleeding (gastric mucosal injury
and gastrointestinal hemorrhage) or using alternative solution (clopidogrel 75mg/d).
The role of physical exercise and training in the management of diabetes mellitus is
more than recommended. This strategy would be helpful in the management of patients
which were also connected with cardiovascular risk, depending on use of other
effective techniques for cardiovascular risk reduction, including statins if necessary,
blood pressure control, and smoking cessation. These combined therapies could be
good alternative, in order to avoid unnecessary surgical treatment. The diabetic patients
have to take special attention to their life style, having more discipline then non-diabetic
patients. Working out is very important for establishment of collateral alternative blood
vessel system, independently of taking aspirin. Of course, continuous taking of ASA
would, maybe, has better effect on clinic benefits for atherosclerosis in diabetic and nondiabetic patients, as well as long-lasting taking; further research is necessary for
confirming this statement. Atherosclerosis as a form of stadium IIa of peripheral artery
disease is significantly reduced by increasing the claudication distance over 500m after
one year of study in diabetic and non-diabetic patients, using this combined therapy.
Strategies for collateral re-vascularization must have been taken into consideration as
well as in the diabetic patients and non-diabetic patients.
5. Conclusion
Interval exercise training strategy and appropriate antiplatelet therapy should been
incorporated into current guidelines for the management of peripheral artery disease in
Fontaine's Stage II in patients who denied and refuse surgical treatment because of its
potential health benefits, in order to avoid certain or potential invasive or minimal
invasive surgical interventions.
References
1. Abbott RD, Brand FN, Kannel WB. (1990). Epidemiology of some peripheral arterial
findings in diabetic men and women: experiences from the Framingham Study. Am J
Med. (88),376-381.
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
28
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
2. Arfvidsson B, Wennmalm A, Gelin J, Dahllof AG, Hallgren B,Lundholm K. (1992).
Co-variation between walking ability and circulatory alterations in patients with
intermittent claudication. Eur J Vasc Surg. (6), 642- 646.
3. American Association of Cardiovascular and Pulmonary Rehabilitation-AACPR.
(2004). Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs.
Champaign, IL: Human Kinetics.
4. Byrne, H., Caulfield, B. & De Vito, G. (2015). Effects of Self-directed Exercise
Programmes on Individuals with Type 2 Diabetes Mellitus: A Systematic Review
Evaluating Their Effect on HbA1c and Other Metabolic Outcomes. Physical
Characteristics, Cardiorespiratory Fitness and Functional Outcomes Sports Med.(26), 10071010.
5. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. (2006).
Aspirin for the primary prevention of cardiovascular events in women and men: a
sex-specific meta-analysis of randomized controlled trials. JAMA (295), 306-13.
6. Brun J, Bordenave S, Mercier J, et al. (2008). Cost-sparing effect of twice-weekly
targeted endurance training in type 2 diabetics: a one-year controlled randomized
trial. Diabetes Metab. 34 (3), 258-265.
7. Criqui
MH,
Denenberg
JO
and
al.
(1998).
The
generalized
nature
of
atherosclerosis:how peripheral arterial disease may predict adverse events from
coronary artery disease. Vasc. Med. (3), 241-245.
8. Creager MA, Luscher TF, Cosentino F, et al. (2003). Diabetes and vascular disease:
pathophysiology, clinical consequences, and medical therapy: part I.Circulation.
(108),1527–1532.
9. Cobbe S, Taylor R, Prescott R, Lee R,Bancroft J, MacEwan S, Shepherd J, Macfarlane
P, Morris A, Jung R,Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese
G,McKnight J, O’Brien I, Semple C, Petrie J, Gordon D, Pringle S, Mac Walter R.
(2008). The prevention of progression of arterial disease and diabetes (POPADAD)
trial: factorial randomised placebo controlled trial of aspirin and antioxidants in
patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:1840.
10. Colwell JA (1997). Aspirin therapy in diabetes (Technical Review). Diabetes Care
(20),1767–1771.
11. Colberg S, Sigal R, Fernhall B, et al. (2010). Exercise and type 2 diabetes: the
American College of Sports Medicine and the American Diabetes Association: joint
position statement executive summary. Diabetes Care. 33(12), 2692–2696.
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
29
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
12. Cai X, Qiu S, Ju C, Sun Z. (2014). Pedometer-based walking intervention and resting
blood pressure in type 2 diabetes: a meta-analysis of randomised controlled studies.
Diabetologia (57),434.
13. Golomb BA, Dang TT, Criqui MH. (2006). Peripheral arterial disease: morbidity and
mortality implications. Circulation (114), 688 –699.
14. Gordon B, Benson A, Bird S, et al. (2009). Resistance training improves metabolic
health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 83 (2),157–175.
15. Hayden M, Pignone M, Phillips C. (2002). Aspirin for the primary prevention of
cardiovascular events: a summary of the evidence for the U.S. Preventive Services
Task Force. Ann Intern Med (136),161–171.
16. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD,
Powell CC, Katzel LI. (2005). Relationship between objective measures of peripheral
arterial disease severity to self-reported quality of life in older adults with
intermittent claudication. J Vasc Surg. (41), 625– 630.
17. Jennings AE, Alberga A, Sigal RJ, et al. (2009). The effect of exercise training on
resting metabolic rate in type 2 diabetes mellitus. Med Sci Sports Exerc. 41(8),1558–
1565.
18. Karstoft K, Winding K, Knudsen SH, et al. (2013). The effects of free-living intervalwalking training on glycemic control, body composition, and physical fitness in type
2 diabetic patients: a randomized, controlled trial. Diabetes Care. 36 (2),228–236.
19. Larsen, O.A., and Lassen, NA. (1966). Effect of daily muscular exercise in patients
with intermittent claudication. Lancet (2), 1093-1096.
20. Larose J, Sigal R, Khandwala F, et al. (2012). Comparison of strength development
with resistance training and combined exercise training in type 2 diabetes. Scand J
Med Sci Sports. 22(4),45–54.
21. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N,Jinnouchi H,
Sugiyama S, Saito Y. (2008). Japanese Primary Prevention of Atherosclerosis With
Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary
prevention of atherosclerotic events in patients with type 2 diabetes: a randomized
controlled trial. JAMA (3)2134 – 2141.
22. Plotnikoff R, Eves N, Jung M, et al. (2010). Multicomponent, home-based resistance
training for obese adults with type 2 diabetes: a randomized controlled trial. Int J
Obes. 34(12), 1733–1741.
23. Snowling NJ, Hopkins WG. (2006). Effects of different modes of exercise training on
glucose control and risk factors for complications in type 2 diabetic patients: a metaanalysis. Diabetes Care. 29(11),2518–2527.
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
30
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
24. Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, Liau CS,
Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. (2007). One-year cardiovascular
event rates in outpatients with atherothrombosis. JAMA (297), 1197–1206.
25. Sigal RJ, Kenny GP, Boulé NG, et al. (2007). Effects of aerobic training, resistance
training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann
Intern Med. 147(6), 357–369.
26. Thomas RJ, Palumbo PJ, Melton LJ 3rd, et al. (2003). Trends in the mortality burden
associated with diabetes mellitus: a population-based study in Rochester, Minn,
1970 –1994. Arch Intern Med. (163),445– 451.
27. Thomas F. Lüscher, MD, Mark A. Creager, MD (2003). Diabetes and Vascular
Disease Pathophysiology, Clinical Consequences, and Medical Therapy: Part II.
Circulation (108), 1655-1661.
28. Thomas D, Elliott EJ, Naughton GA. (2009). Exercise for type 2 diabetes mellitus.
Cochrane Database Syst Rev. (3), 2968.
29. Weiss, EP., Albert,SG., Reeds,DN; Kress,KS; McDaniel, JL., Klein,S and Villareal, DT.
(2016). Effects of matched weight loss from calorie restriction, exercise, or both on
cardiovascular disease risk factors. Am J Clin Nutr.27(3),576-586.
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
31
Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović
CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING
EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC
PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55
Creative Commons licensing terms
Authors will retain the copyright of their published articles agreeing that a Creative Commons Attribution 4.0 International License (CC BY 4.0) terms
will be applied to their work. Under the terms of this license, no permission is required from the author(s) or publisher for members of the community
to copy, distribute, transmit or adapt the article content, providing a proper, prominent and unambiguous attribution to the authors in a manner that
makes clear that the materials are being reused under permission of a Creative Commons License. Views, opinions and conclusions expressed in this
research article are views, opinions and conclusions of the author(s). Open Access Publishing Group and European Journal of Physical Education and
Sport Science shall not be responsible or answerable for any loss, damage or liability caused in relation to/arising out of conflict of interests, copyright
violations and inappropriate or inaccurate use of any kind content related or integrated on the research work. All the published works are meeting the
Open Access Publishing requirements and can be freely accessed, shared, modified, distributed and used in educational, commercial and noncommercial purposes under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
European Journal of Physical Education and Sport Science - Volume 3 │ Issue 2 │ 2017
32